Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

Since 2013 next-generation sequencing (NGS) targeting genes mutated in diffuse gliomas is part of routine diagnostics in our institute. In the present report, we evaluate the use of this custom tailored NGS platform on 434 samples. The NGS panel assesses mutations in ATRX, CIC, EGFR, FUBP1, NOTCH1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Synhaeve, Nathalie E., van den Bent, Martin J., French, Pim J., Dinjens, Winand N. M., Atmodimedjo, Peggy N., Kros, Johan M., Verdijk, R., Dirven, Clemens M. F., Dubbink, Hendrikus J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251173/
https://www.ncbi.nlm.nih.gov/pubmed/30470264
http://dx.doi.org/10.1186/s40478-018-0633-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251173/
https://www.ncbi.nlm.nih.gov/pubmed/30470264
http://dx.doi.org/10.1186/s40478-018-0633-y

Ejemplares similares